In order to check developed software tools, it was necessary to compare estimates of statistical characteristics of annual absorbed plutonium internal doses obtained by PANDORA and IMBA software with the same original data. The results were compared from dose calculations of five cases with different initial data on plutonium inhalation intake, lifetime measurements of plutonium activity in daily urine and post-mortem measurements in lungs, lung lymph nodes, liver and skeleton. Estimates of geometric mean and geometric standard deviation of annual regionally weighted lung dose and bone surface dose were compared. Satisfactory agreements of the estimates of statistical characteristics of annual doses to two critical organs for the selected cases were shown. One hundred individual hyper-realizations (forward model evaluations) are sufficient to calculate MWDS-2013 if only measurements of plutonium activity in daily urine are used, and 2000 individual hyper-realizations if both urine and autopsy measurement results are used.
INTRODUCTION
Southern Ural Biophysics Institute experts developed a special software package called 'PANDORA' (Plutonium Activities aNd DOses hyper-RealizAtions) to calculate MWDS-2013. The term realization typically refers to a set of doses, one for each member of the cohort. In our case, the output of the dosimetry code is not a single value but a probability distribution. The term hyperrealization is thus used to distinguish it from the more familiar usage of the word. Thus a hyper-realization is a set of probability distributions of dose, one for each member of the cohort (1) . PANDORA consists of two modules: a module, 'PANDORA Calculation', calculated hyperrealizations of plutonium doses utilizing the WeLMoS (2) method. Inside one hyper-realization a set of model parameters was generated by Latin Hypercube Sampling, based on the prior distributions of the parameters (3) . The second module, 'PANDORA Analysis' (4) , calculated different individual statistical characteristics of annual doses based on the resulting dose hyper-realizations.
The QA process has been divided into two phases. The first phase (5) dealt with a comparison of organ doses (and bioassay quantities) per unit intake, calculated by two codes IMBA (6, 7) and PANDORA, which were developed independently. Phase I showed that the implementation of the dosimetry agreed to within 1%. This second phase, deals with the generation of Bayesian probability distributions of dose where parameters are allowed to vary within their prior distributions. For this comparison, inhouse code (The IMBA Uncertainty Analyser IMBA_UA which uses IMBA as a subroutine) was compared with PANDORA. Both codes implemented the WeLMoS method (2) independently, but generated their own random parameter values.
Annual regionally weighted lung doses and bone surface cell doses were selected for comparison. Doses to other organs of the systemic pool were not analyzed due to their high correlation with bone surface cell dose. The statistical characteristics of the annual doses compared were the geometric mean (GM) and standard geometric deviation (GSD) from the calculated dose distribution. These were selected because of the lognormal distribution of the results of plutonium urine measurements, which in the simplest case should lead to the same distribution for estimated annual doses.
MATERIALS AND METHODS
For the purpose of comparison of PANDORA and IMBA UA calculations, five cases from the Mayak workers cohort were selected with both lifetime measurements of plutonium in daily urine and post-mortem measurements of plutonium activity in lung, lung lymph nodes, skeleton, and liver.
A three-step plutonium inhalation intake function was used to estimate annual doses (8) . The model works with three compounds-nitrates, oxides, mixtures-as well as three periods when the nuclide could enter a worker's body at different rates. The occupational histories and plutonium urine measurement results are given in Tables 1 and 2 , correspondingly. The results of post-mortem plutonium activity in organs and tissues for the selected cases are shown in Table 3 . 
RESULTS

Case 8088
According to the occupational history and intake model, this worker was in contact with plutonium nitrate only in 1950-53. Figure 1 shows the calculation results for lung and bone surface cells based on only plutonium activity measurements in daily urine and 100 WeLMoS individual hyper-realizations (IHR). It may be seen from Figure 1 that the annual lung dose increased during the contact period and then decreased until the date of death. The values of mean geometric lung doses calculated by both codes are close for all years of plutonium internal exposure. The GSD for lung dose practically did not depend on the year of exposure, but PANDORA's values were a bit larger than these of IMBA. The mean geometric values of annual dose to bone surface cells were practically similar. Unlike the annual regionally weighted lung doses, the GSD value was considerably lower because doses were estimated based on plutonium activity in the worker's daily urine sample, which is more closely connected with the activity in the systemic organs than with the activity in lung regions. It should be noted that the GSD value for bone surface cells dose decreased with time. Figure 2 shows the results of lung and bone surface cells annual doses calculated with both plutonium urine and autopsy measurement results shown in Table 2 . A total of 2000 WeLMoS hyperrealizations (forward model evaluations) were generated.
Case 8442
According to the occupational history this worker was in contact with plutonium oxide in 1949-50. The first two measurements of plutonium in daily urine sample were obtained in late 1969, i.e. about 18 years after the last contact, then five measurements in the early 1976, and the last three in 1981, 2 years before death. Figure 3 shows the calculation results of annual lung and bone surface cell doses performed with plutonium activity measurement in daily urine and 100 WeLMoS IHRs only.
As may be seen from Figure 3 , both regionally weighted lung doses and bone surface cell doses 1945 1950 1955 1960 1965 1970 1975 1980 1985 DLung Geometric Mean, Gy (x/ GSD) show good reproducibility of calculation results. Insignificant discrepancy in doses to bone surface cells in the early years levels off in the late period after the end of contact, when absorbed doses to bone surface cells reach their maximum. Figure 4 shows the calculation results for annual lung and bone surface cell doses with application of measurement results of plutonium activity in both daily urine and autopsy samples using 2000 individual WeLMoS hyper-realizations (forward model evaluations).
As may be seen from Figure 4 , GM values and GSDs for both annual lung and bone surface cell doses show good reproducibility when urine and autopsy data are used. Comparison of the data in Figures 3 and 4 shows that the value of annual doses was practically the same, which confirms the agreement between the urine and autopsy measurement results in this case.
Case 7925
The worker was in contact with only plutonium nitrate during three periods: 1952-57, 1958-70 and 1971-80. Figure 5 shows the calculation results of annual lung and bone surface cells doses performed with plutonium activity measurement in daily urine and 100 WeLMoS hyper-realizations only.
It is seen from Figure 5 that GM values of annual lung doses show good agreement for all three periods of contact with plutonium. The values of GSDs for lung doses in the first two periods calculated with IMBA were lower. During the third period these values were similar. For bone surface cell doses the reproducibility is good for both GM and GSD values, even though only one of 14 measurement results of plutonium activity in daily urine was above the decision threshold (DT). Algorithm of calculation of DT values in compliance with ANSI N13.30-1996 (9) , is shown in the MWDS-2013 paper on measurements results of plutonium in daily urine samples (10) . Figure 6 shows the comparison of the same annual periods with additional use of autopsy data, using 2000 WeLMoS hyper-realizations. Unlike use of urine data only, there is a good reproducibility for both GM and GSD values for lung doses during all three contact periods. It also follows from the figure that the uncertainties of both annual dose and bone surface doses are less than the estimates made with urine data only.
Case 8387
This worker was in contact with plutonium oxide only during two periods: 1956-57 and 1958-59. This case had only three plutonium urine measurements in October 1963, following diethylene triamine penta-acetic acid (DTPA) administration. Despite enhanced plutonium body excretion, two of three measurements were below the DT. Figure 7 shows the calculation results of annual lung and bone surface cell doses performed with plutonium activity measurement in daily urine using only 100 WeLMoS hyper-realizations.
As may be seen from Figure 7 , GM and GSD values for lung doses are similar over time. In the late period after the end of contact, PANDORA gives smaller values of GM and insignificantly larger values of GSD compared to those produced by IMBA. Statistical characteristics of annual doses to bone surface cells are similar. Unlike for case 7925, the uncertainty of annual dose to bone surface cells insignificantly grows with time, due to the fact that all three plutonium measurements were made in 1962, i.e. only three years after the last contact. Figure 8 shows the calculation results for annual lung and bone surface cell doses performed with measurement results of plutonium activity in both daily urine and autopsy samples using 2000 individual WeLMoS hyper-realizations. It can be inferred that the reproducibility of the statistical characteristics of doses to two organs is good.
Case 8505
This worker had the most complicated work history from the entire Mayak Production Association (MPA) workers cohort. This worker consequently came in contact with plutonium oxide, nitrate and then oxide again during the first period, 1949-57. From June 1954 until September 1955, i.e. for over 1 year, the plutonium inhalation contact was interrupted. During the second, 1958-70, and third, 1971-76, periods the worker was exposed to mixed compounds of plutonium, their fraction of total intake for all the periods being 13%. Daily urine samples were collected and analyzed after practically all plutonium had entered the worker's body. All 18 measurements were grouped into three biophysical examinations in 1973, 1975 and 1977 following DTPA administration. In 1973 all three measurement results were above the DT. In 1975 all seven measurements were below the DT, and in 1977 only one out of eight measurements was above DT. Figure 9 shows the calculation results of annual lung and bone surface cells doses performed with the measurement of plutonium activity in daily urine using 100 individual WeLMoS hyper-realizations. It is seen from Figure 9 that for the initial contact period PANDORA gave somewhat greater values of lung annual doses. In the late period the situation changed and then IMBA produced slightly greater lung doses. In the middle of the contact period, GM values of lung doses were similar. The annual doses to bone surface cells were similar during the whole analyzed period. Figure 10 shows the comparison of the same annual doses for case 8505 with additional application of autopsy data using 2000 WeLMoS hyperrealizations. Visually the calculation results of doses to both lungs and bone surface cells under the given conditions look even better than when only urine data were used.
DISCUSSION
From the results of visual comparison it follows that the estimates of GM and GSD for annual lung and bone surface cells doses, performed by PANDORA and IMBA UA, were close for all five cases.
CONCLUSIONS
It can be concluded that the posterior probability distributions of organ doses, calculated by both IMBA_UA and PANDORA are in excellent agreement. Since both codes were developed independently, this lends weight to the fact that there are no significant numerical errors in the PANDORA code. When only measurement results of plutonium activity in daily urine are interpreted,~100 WeLMoS hyper-realizations are sufficient to reach reproducibility. Simultaneous use of measurement results of plutonium activity in daily urine and autopsy samples requires~2000 WeLMoS hyper-realizations. These conclusions are reached mainly by visual inspection of the different outputs. In future work, more objective test statistics will be investigated to demonstrate agreement between the two codes.
Finding the minimal number of hyper-realizations required for the whole Mayak PA workers cohort would require a more detailed analysis. Due to limited computation capacity and the fact that autopsy data were available only for 986 from 8043 Mayak PA workers (11) , which was~12%, it was decided to set a limit to 1000 hyper-realizations to calculate MWDS-2013 for the whole cohort.
